Citation Impact
Citing Papers
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
2018
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
2013
Parenteral Anticoagulants
2012 Standout
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
2010
Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis
2017
Sepsis biomarkers: a review
2010 Standout
Tolerability of different oral iron supplements: a systematic review
2012
Colesevelam Hydrochloride-Ezetimibe Combination Lipid-Lowering Therapy in Patients with Diabetes or Metabolic Syndrome and a History of Statin Intolerance
2007
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Mitochondrial and Immunoallergic Injury Increase Risk of Positive Drug Rechallenge After Drug-Induced Liver Injury
2010
Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia
2004
Statins in tumor suppression
2008
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial
2012
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Antithrombotic Therapy for VTE Disease
2016 Standout
Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
2008
Hemofiltration of Recombinant Hirudin by Different Hemodialyzer Membranes
2007
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2012
Medications in Patients Treated With Therapeutic Plasma Exchange: Prescription Dosage, Timing, and Drug Overdose
2012
Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation
2012
Antithrombotic Therapy for VTE Disease
2012 Standout
Acute kidney injury
2019 Standout
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
p21 in cancer: intricate networks and multiple activities
2009 Standout
Depression in Heart Failure
2006 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial
2007
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
Argatroban therapy in heparin-induced thrombocytopenia
2008
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study
2007
Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty
2014
Atrial fibrillation management: a prospective survey in ESC Member Countries
2005
The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery
2016
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
2019
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
2018
From a glucocentric to a lipocentric approach towards metabolic syndrome
2008
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Drug Removal by Plasmapheresis: An Evidence‐Based Review
2007
Statins and hepatotoxicity
2005
Artificial Intelligence in Cardiology
2018 Standout
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
2012 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials
2022
Argatroban
2009
Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation
2006
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
2010
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study
2008
Trastuzumab-Induced Hepatotoxicity: A Case Report
2013 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
2016
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Self-Management: A Comprehensive Approach to Management of Chronic Conditions
2014 Standout
Current treatment of non‐alcoholic fatty liver disease
2008
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays
2004
Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non‐anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double‐blind placebo‐controlled clinical trial (the PROTECT trial)
2015
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Depression and Coronary Heart Disease
2008 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Large group activity security risk assessment and risk early warning based on random forest algorithm
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Hematological findings and complications of COVID ‐19
2020 Standout
Clinical Utility of B-Type Natriuretic Peptide in Early Severe Sepsis and Septic Shock
2007
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Pre‐operative haematological assessment in patients scheduled for major surgery
2015
Self-monitoring and self-management of oral anticoagulation
2016
Works of Simon de Denus being referenced
Statins and Liver Toxicity: A Meta‐Analysis
2004
Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction
2006
History of Depression as a Predictor of Adverse Outcomes in Patients Hospitalized for Decompensated Heart Failure
2004
Brain Natriuretic Peptide in the Management of Heart Failure
2004
Differences in Biomarkers in Patients With Heart Failure With a Reduced vs a Preserved Left Ventricular Ejection Fraction
2011
A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis
2017
Removal of Lepirudin, a Recombinant Hirudin, by Hemodialysis, Hemofiltration, or Plasmapheresis
2002
Effects of Combined Candesartan and ACE Inhibitors on BNP, Markers of Inflammation and Oxidative Stress, and Glucose Regulation in Patients With Symptomatic Heart Failure
2007
Rate vs Rhythm Control in Patients With Atrial Fibrillation
2005
Early Statin Therapy for Acute Coronary Syndromes
2002
Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction
2013
Clinical Monitoring of Direct Thrombin Inhibitors Using the Ecarin Clotting Time
2002
Decreased Argatroban Clearance Unaffected by Hemodialysis in Anasarca
2003
Oral Ferrous Sulfate Does Not Increase Preoperative Hemoglobin in Patients Scheduled for Hip or Knee Arthroplasty
2011
Rate vs. Rhythm Control in Patients With Atrial Fibrillation. A Meta-Analysis
2005
Impact of a Pharmacist‐Led Warfarin Self‐Management Program on Quality of Life and Anticoagulation Control: A Randomized Trial
2012